<DOC>
	<DOCNO>NCT02326337</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety economical benefit Cyclical Topical Wound Oxygen ( TWO2 ) Therapy treatment chronic diabetic foot ulcer . All subject wear standardized off-loading device use advance moist wound therapy ( AMWT ) dressing . Half subject use TWO2 device , half use sham device .</brief_summary>
	<brief_title>Efficacy , Safety Economic Benefits Topical Wound Oxygen Therapy Treatment Chronic Diabetic Foot Ulcers</brief_title>
	<detailed_description>All subject use TWO2/Sham device 90 minute day home nursing care facility 5 time week treatment phase 12 week . Monitoring wound take place weekly clinic visit safety compliance assessment documentation . Wounds close 12 week continue use TWO2/sham device , off-loading AMWT additional visit two week apart confirm wound closure . All subject whether heal enter follow period additional 12 38 week . The maximum duration participation trial 54 week . During follow-up phase , subject receive standard care accord clinician 's recommendation ask participate another wound care trial period .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Subject document diagnosis Diabetes mellitus Type 1 2 Foot ulcer ankle duration 4 week longer 1 year If index ulcer post amputation wound date surgery must &gt; 30 day 2 week run period le 30 % wound size reduction University Texas Grade 1A , 1B , 1C , 1D , 2A , 2B , 2C , 2D ( Appendix I ) Ulcer ≥ 1cm2 ≤ 20cm2 debridement start runin period If one ulcer present foot , large consider study ( Index ulcer ) Index ulcer must ≥ 1cm away ulcers present foot Adequate perfusion ABI &gt; 0.7 And TcpO2 &gt; 30mmHg OR skin perfusion &gt; 30mmHG OR Toe pressure &gt; 30mmHg OR Duplex biphasic waveform knee No planned revascularization procedure vascular surgery within last/next 30 day Subject and/or caregiver willing able comply specify care visit requirement Subject reasonable expectation complete study ; accord Investigator 's clinical judgment Evidence gangrene part affect limb Documented evidence osteomyelitis part affect limb Index ulcer expose bone Index ulcer exhibit sign severe clinical infection require hospitalization immediate surgical intervention Active Charcot foot study limb Subject participate another investigational device , drug biological trial within last 30 day Uncontrolled diabetes : HbA1c &gt; 12 % Renal dialysis creatinine &gt; 2.5 Known immune insufficiency Chronic steroid use immunosuppressive agent within last three ( 3 ) month anticipate require course study Active treatment malignancy ( specific study limb ) Patient Deep Vein Thrombosis within last 30 day Subject receive growth factor therapy ( e.g. , autologous plateletrich plasma gel , becaplermin , bilayered cell therapy , dermal substitute , extracellular matrix ) within screen period Subject may pregnant time treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>